about
Characterization and evaluation of the artemis camera for fluorescence-guided cancer surgery.Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization.Crosstalk between epidermal growth factor receptor- and insulin-like growth factor-1 receptor signaling: implications for cancer therapy.Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies.Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions.Targeting tumors with nanobodies for cancer imaging and therapy.Nanobody-based cancer therapy of solid tumors.Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy.Nanobody-shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting.Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.Downregulation of EGFR by a novel multivalent nanobody-liposome platform.Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA.Hypoxia-Targeting Fluorescent Nanobodies for Optical Molecular Imaging of Pre-Invasive Breast Cancer.Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid TumorsNanobody-photosensitizer conjugates for targeted photodynamic therapy.Reprint of "Nanobody--shell functionalized thermosensitive core-crosslinked polymeric micelles for active drug targeting".Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.Insights into maleimide-thiol conjugation chemistry: Conditions for efficient surface functionalization of nanoparticles for receptor targeting.Capillary electrophoresis-based assessment of nanobody affinity and purity.EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer.Selective Cytotoxicity to HER2 Positive Breast Cancer Cells by Saporin-Loaded Nanobody-Targeted Polymeric Nanoparticles in Combination with Photochemical InternalizationFusogenic peptides enhance endosomal escape improving siRNA-induced silencing of oncogenesEpidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell linesEGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic TherapyVHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor CellsPatient-Derived Head and Neck Cancer Organoids Recapitulate EGFR Expression Levels of Respective Tissues and Are Responsive to EGFR-Targeted Photodynamic Therapyπ-π-Stacked Poly(ε-caprolactone)-b-poly(ethylene glycol) Micelles Loaded with a Photosensitizer for Photodynamic TherapyImaging of Tumor Spheroids, Dual-Isotope SPECT, and Autoradiographic Analysis to Assess the Tumor Uptake and Distribution of Different NanobodiesPreclinical and Clinical Evidence of Immune Responses Triggered in Oncologic Photodynamic Therapy: Clinical RecommendationsNanobody-Targeted Photodynamic Therapy Selectively Kills Viral GPCR-Expressing Glioblastoma CellsThe Potential of Nanobody-Targeted Photodynamic Therapy to Trigger Immune Responses
P50
Q35578026-23422556-A816-4C5D-B497-7CD86E99F53FQ36564154-DE0D8324-59A6-4360-89F0-03ED9F760F8FQ37597188-630C0A31-6943-450D-9167-6B16DB809C33Q37649827-884FD85E-66A8-4146-A471-811D9463C3F9Q37662855-B710B120-7743-47ED-B075-16477CC36D86Q37676077-5190C898-8C5D-46E7-A20E-2766C44DC589Q38137610-7BE33D55-8BC3-4FA6-AD1F-E7226DE61368Q38322471-6E8423B0-E63F-4EA2-BFFF-3AEB9F238EE5Q38787937-8F610D9D-3AB0-445F-BFCB-B51D22C117C0Q39603707-034D6C62-00EC-4CDF-9D8F-FB72C34A9FF2Q39640877-ABCFBCA0-AF37-467B-A647-CFA7BE38613FQ39719545-D34F42A3-0953-45F2-A5EA-569FBA34F5AAQ40162185-FE99F4FC-E9E0-4C6B-9826-359AF77D3850Q42121913-073D0EF3-00DF-4BA3-A763-E8394972FB38Q42655550-97E788DD-2B66-4A9B-9845-088624DFB0B2Q42808391-750E0D09-C608-467C-B5AA-0C8CC2E51F34Q42809203-D1367D9D-34B7-490D-AF91-4EA06EAA5865Q46146478-AFE667D5-7961-4B0F-B83B-0EBE593F9190Q46422598-54C352DD-7E06-4E23-8779-ABFD345788B3Q46557148-F816AEC5-093B-4F52-B6D6-2F6EE982C1DBQ52727297-9FBEC6C4-4DE3-4E6E-9DE6-8C404A97CD5FQ53062674-5BBFA115-9A24-4DAA-8352-3217B1D05E77Q54207291-87FF2642-2A03-4391-A37E-2D95060A8045Q64090598-1C3A0838-4CFD-42ED-8843-865A69968873Q79450299-F9F1EA30-5691-4D0E-B590-C36260310741Q88734278-5010CD68-9457-413B-8B9E-A1C5F505C74FQ90108492-7D78068B-ACB9-4070-802A-5C8BD3856852Q90211933-62EB0207-FC92-4DBC-9DC4-7235921AC9E8Q91147891-C12BA5D3-9E22-4D4B-AE94-9DFF11D58CCDQ91869875-C7AC2A05-5E57-4226-AA13-995A98ACF493Q92289216-6018835E-7577-4D1B-885C-9BD49DF2E1F5Q93003250-D5239A9F-A3ED-42A3-8320-D30B61F315CFQ93058934-0C0CEE9E-6DC6-49D6-81F0-474C038422C6Q93189908-9AAA5E58-F03D-4AA2-8B7E-F54F9A2AD2CD
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sabrina Oliveira
@ast
Sabrina Oliveira
@en
Sabrina Oliveira
@es
Sabrina Oliveira
@nl
Sabrina Oliveira
@sl
type
label
Sabrina Oliveira
@ast
Sabrina Oliveira
@en
Sabrina Oliveira
@es
Sabrina Oliveira
@nl
Sabrina Oliveira
@sl
prefLabel
Sabrina Oliveira
@ast
Sabrina Oliveira
@en
Sabrina Oliveira
@es
Sabrina Oliveira
@nl
Sabrina Oliveira
@sl
P108
P106
P21
P31
P496
0000-0002-6011-2122